West Virginia Attorney General Patrick Morrisey said the state will receive more than $153,000 in a national settlement with a prescription drug manufacturer.
Morrisey says in a news release last month that every state and the District of Columbia are participating in the $13.5 million settlement with Boehringer Ingelheim Pharmaceuticals Inc.
The settlement resolves allegations that the company misrepresented the effectiveness of four drugs in treating or managing certain health conditions, including heart attacks, congestive heart failure and chronic obstructive pulmonary disease. The drugs are Micardis, Aggrenox, Atrovent and Combivent.
Topics Virginia
Was this article valuable?
Here are more articles you may enjoy.
How Insurers Can Gain the Most Value From Their AI Investments: Accenture 
AXA XL Launches Insurance Company, AXA XL E&S 
Full Senate Passes Measure to Reauthorize Federal Terrorism Insurance Backstop 
New Jersey Employers Should Prepare Now for Oct. 1 Independent Contractor Rule 
